Regeneron Pharmaceuticals has received FDA emergency approval to use a combination of coronavirus drugs based on antibodies injected together - Casirivimab and Imdevimab. The combination therapy is approved for mild to moderate form of COVID-19 in adults and children from 12 years old, who are at high risk of progression to severe disease.